Reporting transfusion-related acute lung injury by clinical and preclinical disciplines.

BACKGROUND Disciplines involved in diagnosing transfusion-related acute lung injury (TRALI) report according to a "one-hit" theory. However, studies showed that patients with an underlying condition are at increased risk of the development of TRALI. We investigated whether accumulating evidence on the "two-hit" theory has changed the practice of reporting TRALI. MATERIALS AND METHODS Departments of haematology, haemovigilance, transfusion medicine, intensive care and anaesthesiology from all Dutch hospitals with at least five beds equipped for mechanical ventilation were invited to participate in an online survey. Using clinical vignettes with conjoint analysis we investigated the effect of patients' age, admission diagnosis, type and number of transfusions and presence of risk factors for acute lung injury on TRALI reporting. A positive β-coefficient indicated a higher likelihood of reporting TRALI. RESULTS We received 129 questionnaires (response rate 74%). Respondents were more likely to report TRALI in younger patients, if symptoms developed within 2 hours of transfusion and if patients had received multiple transfusions. Sepsis and the presence of a risk factor for acute lung injury reduced the inclination to report. Transfusion medicine physicians and haemovigilance staff no longer took the age of transfusion products into account in their diagnostic considerations on TRALI. DISCUSSION We conclude that the multidisciplinary team involved in TRALI reporting, still considers TRALI a "one-hit" event, despite accumulating evidence that supports the "two-hit" theory. These results suggest that the patients most at risk of developing TRALI are not reported to the blood bank.

[1]  Low Risk , 2020, Definitions.

[2]  R. Lutter,et al.  Transfusion of 35-Day Stored RBCs in the Presence of Endotoxemia Does Not Result in Lung Injury in Humans* , 2016, Critical care medicine.

[3]  A. Vlaar,et al.  Redefining transfusion‐related acute lung injury: don't throw the baby out with the bathwater , 2016, Transfusion.

[4]  A. Vlaar,et al.  Antibody‐mediated transfusion‐related acute lung injury; from discovery to prevention , 2015, British journal of haematology.

[5]  P. Bacchetti,et al.  Recipient clinical risk factors predominate in possible transfusion‐related acute lung injury , 2015, Transfusion.

[6]  Jeannie Callum,et al.  Age of transfused blood in critically ill adults. , 2015, The New England journal of medicine.

[7]  G. Angelini,et al.  Liberal or restrictive transfusion after cardiac surgery. , 2015, The New England journal of medicine.

[8]  J. Binnekade,et al.  Low‐risk transfusion‐related acute lung injury donor strategies and the impact on the onset of transfusion‐related acute lung injury: a meta‐analysis , 2015, Transfusion.

[9]  N. Juffermans,et al.  Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside. , 2015, Blood reviews.

[10]  E. Murphy,et al.  Prospective Study on the Clinical Course and Outcomes in Transfusion-Related Acute Lung Injury* , 2014, Critical care medicine.

[11]  S. Sowemimo-Coker,et al.  Antibodies to the HLA‐A2 antigen prime neutrophils and serve as the second event in an in vitro model of transfusion‐related acute lung injury , 2014, Vox sanguinis.

[12]  K. Tadokoro,et al.  Novel swine model of transfusion‐related acute lung injury , 2012, Transfusion.

[13]  M. Popovsky,et al.  How we view and approach transfusion‐associated circulatory overload: pathogenesis, diagnosis, management, mitigation, and prevention , 2013, Transfusion.

[14]  N. Juffermans,et al.  Transfusion-related acute lung injury: a clinical review , 2013, The Lancet.

[15]  R. Weiskopf,et al.  Transfusion-related acute lung injury: incidence and risk factors. , 2012, Blood.

[16]  Marcus J Schultz,et al.  The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. , 2011, Blood.

[17]  J. Fraser,et al.  A novel in vivo ovine model of transfusion‐related acute lung injury (TRALI) , 2011, Vox sanguinis.

[18]  H. van Lenthe,et al.  Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. , 2010, Blood.

[19]  R. Nieuwland,et al.  Supernatant of Aged Erythrocytes Causes Lung Inflammation and Coagulopathy in a “Two-Hit” In Vivo Syngeneic Transfusion Model , 2010, Anesthesiology.

[20]  R. Lutter,et al.  Mechanical ventilation aggravates transfusion-related acute lung injury induced by MHC-I class antibodies , 2010, Intensive Care Medicine.

[21]  J. Binnekade,et al.  Risk factors and outcome of transfusion-related acute lung injury in the critically ill: A nested case–control study* , 2010, Critical care medicine.

[22]  O. Gajic,et al.  The practice of reporting transfusion‐related acute lung injury: a national survey among clinical and preclinical disciplines , 2010, Transfusion.

[23]  M. Matthay,et al.  Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. , 2009, The Journal of clinical investigation.

[24]  E. Moore,et al.  Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. , 2009, Blood.

[25]  J. G. van der Bom,et al.  The role of donor antibodies in the pathogenesis of transfusion‐related acute lung injury: a systematic review , 2008, Transfusion.

[26]  M. Schultz,et al.  [Transfusion-related acute lung injury (TRALI) in the Netherlands in 2002-2005]. , 2008, Nederlands tijdschrift voor geneeskunde.

[27]  A. Leaver,et al.  Acute lung injury after ruptured abdominal aortic aneurysm repair: The effect of excluding donations from females from the production of fresh frozen plasma* , 2008, Critical care medicine.

[28]  M. Malinchoc,et al.  Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. , 2007, American journal of respiratory and critical care medicine.

[29]  U. Sachs,et al.  The pathogenesis of transfusion‐related acute lung injury (TRALI) , 2007, British journal of haematology.

[30]  H. Cohen,et al.  Serious hazards of transfusion: a decade of hemovigilance in the UK. , 2006, Transfusion medicine reviews.

[31]  S. Kleinman A perspective on transfusion‐related acute lung injury two years after the Canadian Consensus Conference , 2006, Transfusion.

[32]  R. Bohle,et al.  Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. , 2006, Blood.

[33]  J. Manners,et al.  A perspective. , 2006, Annals of cardiac anaesthesia.

[34]  S. Loer,et al.  Transfusion‐related acute lung injury: lack of recognition because of unawareness of this complication? , 2005, European journal of anaesthesiology.

[35]  C. Férec,et al.  [Transfusion related acute lung injury (TRALI): an unrecognised pathology]. , 2005, Pathologie-biologie.

[36]  J. Freedman,et al.  Proceedings of a consensus conference: towards an understanding of TRALI. , 2005, Transfusion medicine reviews.

[37]  Peter A Lachenbruch,et al.  Fatalities caused by TRALI. , 2004, Transfusion medicine reviews.

[38]  C. Chapman,et al.  Transfusion‐related acute lung injury caused by two donors with anti‐human leucocyte antigen class II antibodies: a look‐back investigation , 2004, Transfusion medicine.

[39]  J. Wallis Transfusion-related acute lung injury (TRALI)--under-diagnosed and under-reported. , 2003, British journal of anaesthesia.

[40]  Lynda Aiman-Smith,et al.  Conducting Studies of Decision Making in Organizational Contexts: A Tutorial for Policy-Capturing and Other Regression-Based Techniques , 2002 .

[41]  P. Holland,et al.  Transfusion-Related Acute Lung Injury Report of a Clinical Look-Back Investigation , 2002 .

[42]  F. Becker,et al.  Transfusion‐related acute lung injury due to HLA‐A2‐specific antibodies in recipient and NB1‐specific antibodies in donor blood , 1996, British journal of haematology.